Most families arrive at a memory clinic with one clear question: what’s wrong with my relative? But by focusing only on diagnosis, they overlook dozens of critical details that will shape treatment decisions, quality of life, and how quickly decline progresses. The questions that get forgotten—about medication side effects, how the diagnosis will affect their driving privileges, whether the clinic’s recommended treatments are covered by insurance, or what to expect if the condition worsens—are often the ones that matter most in the weeks and months after the visit. A family might spend an hour getting a diagnosis of mild cognitive impairment and leave without understanding how much of their parent’s memory loss is reversible, which of their parent’s daily activities are actually at risk, or whether the proposed medication has interactions with the five other drugs their parent takes. This gap between what families ask and what they need to know is predictable, wide, and avoidable—if they prepare beforehand.
Table of Contents
- Which Current Medications Could Contribute to Memory Problems?
- What Tests Were Done and Which Ones Were Skipped?
- How Will This Diagnosis Change My Relative’s Legal Rights and Responsibilities?
- What Does Treatment Actually Look Like, and What Won’t It Do?
- What If the Memory Loss Gets Worse? What’s the Trajectory?
- Are There Any Reversible Causes We Haven’t Ruled Out?
- What Should We Tell My Relative About the Diagnosis and These Results?
- Frequently Asked Questions
Which Current Medications Could Contribute to Memory Problems?
Families rarely ask this question, but doctors at memory clinics hear it regularly: “Why didn’t we ask about this months ago?” Certain prescription medications are known to impair cognition or worsen existing memory loss—anticholinergics (used for bladder control or allergies), benzodiazepines (anti-anxiety drugs like lorazepam), statins (cholesterol drugs), sleep aids, and opioids are common culprits. A 78-year-old woman attributed her mother’s declining memory to early dementia, only to discover at the clinic that three of the five medications her mother took were on the pharmacy’s “beers criteria” list of drugs that pose higher risks in older adults. The memory loss improved significantly once two medications were switched.
This isn’t a rare scenario—medication review is a standard part of memory evaluation, but families don’t always volunteer a complete, detailed medication list (including over-the-counter supplements, which can interact dangerously). If a family member takes Benadryl for allergies, melatonin for sleep, a statin, and two blood pressure drugs, the combination may be eroding cognition more than any underlying disease. Clinics will ask about medications, but they’ll ask more thoroughly and catch more interactions if the family brings a written list of every medication, dosage, and how long each has been taken.
What Tests Were Done and Which Ones Were Skipped?
memory clinics typically perform cognitive screening tests during the visit—short mental status exams that take 10 to 15 minutes. families often assume these tests are comprehensive, but they’re not. A standard Mini-Cog or Montreal Cognitive Assessment might catch obvious decline but miss subtle changes in executive function or specialized memory types.
Advanced imaging (MRI or PET scans), blood biomarker tests (checking for amyloid or tau proteins linked to Alzheimer’s), and genetic testing for APOE4 status are more thorough but expensive, may not be covered by insurance, and aren’t always recommended for every patient. One family was told their father had “mild cognitive impairment” based solely on a 10-minute office test, but when they later pursued an MRI at their own expense, it revealed a large, unrelated tumor pressing on his brain—the “memory loss” wasn’t actually dementia at all. Families should explicitly ask which tests the clinic performed, which tests they considered but didn’t do (and why), and whether additional testing would change treatment. If the diagnosis will affect major life decisions—stopping driving, moving into assisted living, major medications—the family should understand whether the testing that led to that diagnosis was standard, limited, or part of a comprehensive workup.
How Will This Diagnosis Change My Relative’s Legal Rights and Responsibilities?
This question is almost never asked in the clinic visit, and yet the answer carries enormous consequences. A diagnosis of dementia or mild cognitive impairment can affect the person’s ability to sign legal documents, manage their own finances, make medical decisions, and hold a driver’s license. In some states, a physician can report a cognitive diagnosis to the DMV, which may trigger a driving test or license suspension. A diagnosis can also be entered into medical records and insurance claims, which insurance companies may use later to exclude someone from policies or services.
Some families want a diagnosis documented (for legal protection, to qualify for caregiver benefits, or to ensure the person isn’t accidentally given medications that worsen cognitive decline). Others worry that a diagnosis will trigger unwanted legal actions or discrimination. The clinic staff aren’t lawyers, but they should know the reporting requirements in their state and the local legal implications of the diagnosis. Families should ask: “Are you required to report this diagnosis to the DMV or anyone else? Will this affect my relative’s legal authority to make decisions? Should we consult an elder law attorney before or after this diagnosis becomes official?”.
What Does Treatment Actually Look Like, and What Won’t It Do?
Families often arrive at memory clinics expecting a cure or at least a clear path to slowing decline. The reality is murkier. Current medications (donepezil, rivastigmine, galantamine for Alzheimer’s; memantine for moderate to severe disease) can modestly slow cognitive decline in some people for a limited time, but they don’t reverse loss that has already occurred, and they don’t work for everyone.
Newer drugs like lecanemab (Leqembi) show promise for early-stage Alzheimer’s but require regular infusions, monitoring for amyloid-related imaging abnormalities (a rare but serious side effect), and cost thousands of dollars per year. Families should ask the clinician: “What does this medication actually do? How long does it typically slow decline? What happens if my relative stops taking it? How will we know if it’s working?” Many people tolerate medications with minimal side effects, but some experience nausea, muscle cramps, or worsening cognition—responses the clinic won’t know about unless the family reports them at follow-up. The conversation should also include what won’t be treated: many people with cognitive impairment also have depression, sleep disruption, or anxiety, which can be addressed but often aren’t part of the standard memory clinic visit. Families should ask whether their relative should see a neuropsychologist, psychiatrist, or sleep specialist in addition to the memory clinic.
What If the Memory Loss Gets Worse? What’s the Trajectory?
Families rarely ask about the future during a first memory clinic visit, often because the diagnosis itself feels overwhelming. But understanding the likely progression—how fast the decline might happen, what abilities will be affected first, when (or if) the person will need full-time care—is essential for planning. The trajectory varies wildly. Some people with mild cognitive impairment progress to dementia within a few years; others remain stable for a decade or longer. Younger-onset Alzheimer’s (diagnosed before age 65) often progresses faster than late-onset.
Vascular dementia can progress in steps (stable for months, then a sudden decline). Frontotemporal dementia, which is rare but devastating, can cause personality changes and loss of judgment before memory loss becomes obvious. Families should ask: “Based on the specific type of cognitive loss my relative has, what’s the likely timeline? Could this progress to where she needs 24-hour care? What will be the first signs that it’s getting worse? Are there milestones we should plan around?” This isn’t morbid—it’s practical. A family that understands their relative might need assisted living within 3 to 5 years can start researching communities now, discuss moving options while their relative can still participate in the decision, and arrange finances accordingly. A family that doesn’t ask might be blindsided.
Are There Any Reversible Causes We Haven’t Ruled Out?
Some memory loss is permanent, but some isn’t. Thyroid dysfunction, vitamin B12 deficiency, depression, sleep apnea, and normal-pressure hydrocephalus can all mimic dementia and are potentially treatable.
A 70-year-old man was diagnosed with Alzheimer’s based on cognitive screening and family history, but his daughter pushed for blood work and discovered severe vitamin B12 deficiency—the memory loss reversed almost entirely once he started B12 supplementation. Memory clinics typically screen for the most common reversible causes (thyroid, B12), but not always thoroughly, and not for every person. Families should ask: “What reversible causes has my relative been tested for? Are there any others we should consider?”.
What Should We Tell My Relative About the Diagnosis and These Results?
Families often leave the clinic with a diagnosis and no clear answer to this question. Should they tell their relative they’ve been diagnosed with dementia? If so, when and how? The answer depends on the person’s insight into their own changes, their emotional resilience, whether the diagnosis will affect their daily life, and what treatments or monitoring they’ll undergo. Many people with early-stage dementia benefit from knowing their diagnosis—it explains changes they’ve noticed, allows them to participate in care planning while they can, and removes the anxiety of not knowing why they’re forgetting things. Others react with denial, depression, or catastrophizing that makes the news harder on everyone.
The clinic should guide the family on this question, but families have to raise it. It’s equally important to ask what language to use—terms like “dementia” and “Alzheimer’s disease” carry stigma and fear. Saying “you have changes in memory and thinking that we’re going to monitor and treat” conveys information without the weight of a label, and some people respond better to that framing. The family should ask the clinician: “Should we tell my relative about this diagnosis? How should we explain it? What should we tell other family members or friends?”.
Frequently Asked Questions
Can memory loss from medication be reversed?
Sometimes. If the medication is causing the memory loss and it’s stopped or switched quickly, improvement can occur within weeks to months. However, if damage has already progressed or the person has been on the medication for years, the memory loss may only partially improve. This is why early recognition is important.
What’s the difference between mild cognitive impairment and dementia?
Mild cognitive impairment (MCI) is measurable decline in memory or thinking that doesn’t significantly impair daily function. Dementia involves decline severe enough to interfere with work, social life, or self-care. Someone with MCI may progress to dementia, stay stable, or even improve. The trajectory isn’t fixed.
Should we get a second opinion after a memory clinic diagnosis?
If the diagnosis will lead to significant treatment, legal changes, or life decisions, a second opinion from another neurologist or geriatrician can be valuable. It’s especially worth considering if the diagnosis is early-stage Alzheimer’s and the clinic is recommending an expensive new medication.
Can family members be tested to see if they’ll develop dementia?
Genetic testing for APOE4 status (which increases Alzheimer’s risk) is available, but most experts don’t recommend routine screening of family members without symptoms. Having the gene doesn’t mean someone will develop dementia. Discuss with a genetic counselor or neurologist whether testing makes sense for your situation.
What happens at a follow-up memory clinic visit?
Follow-up visits typically reassess cognition using similar tests, review medication side effects and response, check for changes in function or behavior, and discuss whether treatment should continue, change, or stop. Most clinics schedule follow-ups every 6 to 12 months initially.
If my relative refuses to go to a memory clinic, what can we do?
Forcing someone into an evaluation rarely works. Instead, frame the visit as a general health check-up rather than a test for dementia. Involve their primary care doctor in recommending the referral. Let them know the clinic will explain what’s happening in their memory rather than blame or judge. Some people are more willing to attend if a trusted family member goes with them.
